Gland Pharma Limited (GLAND.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 279.46B |
| Enterprise Value | 248.7B |
| P/E Ratio | 39.47 |
| PEG Ratio | 0.84 |
| Price/Sales Ratio | 6.31 |
| Price/Book Ratio | 3.91 |
| Enterprise/Revenue | 5.84 |
| Enterprise/EBITDA | 19.64 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 64.31B |
| Revenue/Share | 390.39 |
| Gross Profit | 19.32B |
| EBITDA | 19.22B |
| Net Income | 10.27B |
| Diluted EPS | 62.28 |
Balance Sheet
| Total Cash | 34.33B |
| Total Cash/Share | 208.4 |
| Total Debt | 2.84B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 4.68 |
| Book Value Per Share | 628.81 |
Price History
| 52-Week Change | 30.25 |
| 52-Week High | 2,573.5 |
| 52-Week Low | 1,573.6 |
| Moving Average 50 Days | 2,223.75 |
| Moving Average 200 Days | 1,889.84 |
Statistics
| Average Volume | 657,151 |
| Shares Outstanding | 164.96M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 38 |
| Trailing Annual Dividend Yield | 1.54 |
| Payout Ratio | 0.29 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
